Anti-IL-20 antibodies and binding partners and methods of using in inflammation

Details for Australian Patent Application No. 2004223836 (hide)

International Classifications

Event Publications

13 October 2005 PCT application entered the National Phase

PCT publication WO2004/085475 Priority application(s): WO2004/085475

20 October 2005 Amendment Made

The nature of the amendment is as shown in the statement(s) filed 23 Sep 2005

24 November 2005 Section 223 Application Received

ZymoGenetics, Inc. An application to extend the time from 06 Oct 2004 to 06 Oct 2005 in which to comply with Section 6 (c) has been filed . Address for service in Australia - Spruson & Ferguson Level 35 St Martins Tower 31 Market Street Sydney NSW 2000

19 January 2006 Section 223 Application Allowed

ZymoGenetics, Inc. The time in which to comply with Section 6 (c) has been extended to 06 Oct 2005. Address for service in Australia - Spruson & Ferguson Level 35 St Martins Tower 31 Market Street Sydney NSW 2000

20 October 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.